Home » Topics » BioWorld Science

BioWorld Science
RSS

University of California patents compounds for periodontal disease

Oct. 1, 2019

Chinese researchers describe new HIV antivirals

Oct. 1, 2019

NantKwest studies PD-L1 t-haNK for locally advanced or metastatic solid cancers in phase I

Oct. 1, 2019

U.S. investigators identify new apoptosis inducers for cancer

Oct. 1, 2019

AnaptysBio reports phase II interim data on ANB-019 in generalized pustular psoriasis

Oct. 1, 2019

FDA issues complete response letter for PT-010 for COPD

Oct. 1, 2019

Janssen presents free fatty acid FFA1 and/or FFA4 receptor agonists

Oct. 1, 2019

Chinese investigators patent CDK4 and/or CDK6 inhibitors

Oct. 1, 2019

Phase III RESTORE-IMI 2 trial of Recarbrio in HABP/VABP meets primary endpoint

Oct. 1, 2019

Annexon reports phase Ib data on ANX-005 in Guillain-Barre syndrome

Oct. 1, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...